SM

Seema Maurya

Active Director Director DIN 03097170
DIN 03097170 First appointment Jul 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2010
Shareholding value •••• Premium profile

About Seema Maurya

Data last updated:

Seema Maurya is a Director at Samesia Biotech Private Limited (since 2010). The company operates in Pharma. Samesia Biotech Private Limited reported revenue of ₹36 Lakh (FY 2025).

DIN 03097170
Primary Designation Director
Industry Pharma
First Appointment 23 Jul 2010
Oldest Company Age 16 yrs
Largest company Samesia Biotech Private Limited · ₹36 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Samesia Biotech Private Limited U74900UP2010PTC041447
Director23 Jul 20102010₹36 Lakh (FY 2025)Active

Board colleagues of Seema Maurya

Directorship timeline

Open interactive timeline →
Samesia Biotech Private Limited
Premium access

Shareholding and investment profile for Seema Maurya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Maurya

Seema Maurya currently holds 1 directorship: Samesia Biotech Private Limited (Director, since 23 Jul 2010, revenue ₹36 Lakh (FY 2025)).

Seema Maurya was first appointed on 23 Jul 2010 as Director at Samesia Biotech Private Limited.

The current boards of Seema Maurya's companies include Deo Prakash (Samesia Biotech Private Limited), Manoj Kumar Maurya (Samesia Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available